IRC Section 409A
A Lurking Beast for Privately Held Companies
Lynton Kotzin, CPA, ABV, CFA, ASA, CBA and Don Wenk, CPA, ABV, CFA, ASA
While stock option backdating scandals for public companies have littered the business pages for months now, many privately held companies are likely grappling with their own stock option headaches. Those headaches come courtesy of Internal Revenue Code 409A.
Section 409A was included in the American Jobs Creation Act of 2004. Section 409A codifies standards for nonqualified deferred compensation. With limited exclusions, any plan that defers taxable compensation for employees is covered, including stock appreciation rights and stock options. Employee stock options generally fall into two categories, qualified or statutory options, and non-qualified options (also called NSOs). The impact of 409A will be felt primarily on holders and issuers of NSOs. NSOs generally are taxable at the date of their exercise and not at their grant or vesting. Section 409A preserves this treatment, but only if it can be shown that the stock option is granted with an exercise price at or above the fair market value of the underlying stock on the date of grant. A stock option granted with a per share exercise price that is less than the fair market value per share of a company’s underlying stock on the date of grant is treated as deferred compensation under the Act. With certain limited exceptions, this determination will result in tax at the time of vesting as opposed to at exercise, and an additional 20 percent tax on the optionee, and other potential penalties. Given these penalties, it will become vital that private companies, which do not have an active marketplace dictating the fair market value of the company’s shares, take action to ensure that the estimated fair market value of the company as of an option grant date is reasonable and defensible.
Proposed Regulations issued under Section 409A on
The
If, however, a company chooses to adopt one of the “presumptive” stock valuation methods set forth in the proposed regulations, the burden rests on the IRS to prove both that the option’s exercise price was below fair market value, and that the company’s application of the presumptive method was “grossly unreasonable.”
There are three valuation methods that will be presumed reasonable under the regulations if consistently used to value underlying stock for all of a company’s equity-based compensation arrangements. The valuation resulting from any of these methods will be considered to be fair market value and may be rebutted by the IRS only if the company’s application of these methods is found to be “grossly unreasonable.”
The three methods, (called presumptive valuation methods) are (a) the independent appraisal presumption, (b) the illiquid start-up presumption, and (c) the binding formula presumption.
Under the independent appraisal presumption, a valuation performed by a qualified independent appraiser using traditional appraisal methodologies will be presumed to be reasonable if it values the stock as of a date that is no more than 12 months before the related stock option grant date. This presumption would not apply if events subsequent to the appraisal date have a material effect on the value of the stock.
The illiquid start-up presumption is a special presumption available only to a privately-owned company which is less than 10 years old. Under this presumption, a valuation will be considered reasonable if it is evidenced by a written report and is performed by a person with “significant knowledge and experience or training in performing similar valuations.” In addition, the valuation must take into account certain “valuation factors” specified in the proposed regulations. Finally, the valuation cannot be more than 12 months old, nor can there have been a significant event (financing, IPO, etc.) since the performance of the valuation, nor can there be a reasonable anticipation of an IPO, sale or change of control of the company within 12 months following the equity grant to which the valuation applies.
Under the binding formula presumption, a valuation will be presumed reasonable if it is based on a formula which is used in a shareholder buy-sell agreement or similar binding agreement. The formula must also be used for all non-compensatory purposes requiring the valuation of the company’s stock.
In summary, the arrival of IRC 409A will increase the accountability of company management to new levels regarding employee deferred or non-cash compensation. We believe that the boards of companies that use these forms of employee compensation will have to work in close conjunction with the company’s accountants, attorneys and valuation advisors to determine fair market values at various intervals and document the methodologies utilized to determine these values. The days of management using rules of thumb and “best guesses” to set employee stock option exercise prices are over, and the continued use of these short-cuts will only result in many more headaches for management.
Lynton M. Kotzin, CPA, ABV, CFA, ASA, CBA, CIRA, is vice president and Don Wenk, CPA, ABV, CFA, ASA, is director with Ringel Kotzin Valuation Services. They can be contacted at (602) 266-5060, ext. 102, or go to www. rkvaluation. com.
AZ CPA – February 2007


